Correction: Chiral Se@CeO2 superparticles for ameliorating Parkinson's disease
Abstract
Correction for ‘Chiral Se@CeO2 superparticles for ameliorating Parkinson's disease’ by Ximing Liu et al., Nanoscale, 2023, https://doi.org/10.1039/d2nr04534f.
We are excited to let you know that our journals content will be migrating to the Silverchair platform, with a planned launch in summer 2026.
All of our content will still be hosted at pubs.rsc.org and the new platform will provide a more intuitive reading and navigation experience, along with improved discovery and indexing of your work.
Details on the move can be found in our partnership announcement.
* Corresponding authors
a
International Joint Research Laboratory for Biointerface and Biodetection, Jiangnan University, Wuxi, Jiangsu, People's Republic of China
E-mail:
hcl@jiangnan.edu.cn, xlg@jiangnan.edu.cn
b State Key Laboratory of Food Science and Technology, Jiangnan University, Jiangsu, People's Republic of China
Correction for ‘Chiral Se@CeO2 superparticles for ameliorating Parkinson's disease’ by Ximing Liu et al., Nanoscale, 2023, https://doi.org/10.1039/d2nr04534f.
Please wait while we load your content...
Something went wrong. Try again?
X. Liu, H. Zhang, C. Hao, H. Kuang, C. Xu and L. Xu, Nanoscale, 2023, 15, 5092 DOI: 10.1039/D3NR90035E
This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.
Read more about how to correctly acknowledge RSC content.
Fetching data from CrossRef.
This may take some time to load.
Loading related content